- Home
- RIGL vs WOW Comparison
RIGL vs WOW Comparison
Compare RIGL & WOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- WOW
- Stock Information
- Founded
- RIGL 1996
- WOW 2001
- Country
- RIGL United States
- WOW United States
- Employees
- RIGL N/A
- WOW N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- WOW Cable & Other Pay Television Services
- Sector
- RIGL Health Care
- WOW Telecommunications
- Exchange
- RIGL Nasdaq
- WOW Nasdaq
- Market Cap
- RIGL 335.5M
- WOW 285.5M
- IPO Year
- RIGL 2000
- WOW 2017
- Fundamental
- Price
- RIGL $38.85
- WOW $5.09
- Analyst Decision
- RIGL Buy
- WOW Hold
- Analyst Count
- RIGL 5
- WOW 2
- Target Price
- RIGL $38.20
- WOW $5.20
- AVG Volume (30 Days)
- RIGL 995.6K
- WOW 3.4M
- Earning Date
- RIGL 08-05-2025
- WOW 08-11-2025
- Dividend Yield
- RIGL N/A
- WOW N/A
- EPS Growth
- RIGL N/A
- WOW N/A
- EPS
- RIGL 5.43
- WOW N/A
- Revenue
- RIGL $267,921,000.00
- WOW $604,800,000.00
- Revenue This Year
- RIGL $59.93
- WOW N/A
- Revenue Next Year
- RIGL N/A
- WOW N/A
- P/E Ratio
- RIGL $7.15
- WOW N/A
- Revenue Growth
- RIGL 105.62
- WOW N/A
- 52 Week Low
- RIGL $12.66
- WOW $3.06
- 52 Week High
- RIGL $43.72
- WOW $5.79
- Technical
- Relative Strength Index (RSI)
- RIGL 68.57
- WOW 77.52
- Support Level
- RIGL $39.00
- WOW $5.06
- Resistance Level
- RIGL $42.08
- WOW $5.12
- Average True Range (ATR)
- RIGL 2.32
- WOW 0.03
- MACD
- RIGL -0.37
- WOW 0.03
- Stochastic Oscillator
- RIGL 53.26
- WOW 70.00
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.